COVID-19: Pháp chuẩn bị thử nghiệm lâm sàng 3 loại thuốc điều trị

(TTXVN/Vietnam+) 08:25 12/03/2020

Ngày 11/3, Bộ Nghiên cứu Pháp cho biết nước này sẽ bắt đầu chiến dịch thử nghiệm lâm sàng 3 loại thuốc trị bệnh COVID-19 mang tên Discovery vào cuối tuần này hoặc đầu tuần sau. Tổng cộng sẽ có 800 bệnh nhân Pháp bị nhiễm virus SARS-CoV-2 tham gia chương trình thử nghiệm này. Họ được chia thành 4 nhóm.

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